COVID-19: Pháp chuẩn bị thử nghiệm lâm sàng 3 loại thuốc điều trị

(TTXVN/Vietnam+) 08:25 12/03/2020

Ngày 11/3, Bộ Nghiên cứu Pháp cho biết nước này sẽ bắt đầu chiến dịch thử nghiệm lâm sàng 3 loại thuốc trị bệnh COVID-19 mang tên Discovery vào cuối tuần này hoặc đầu tuần sau. Tổng cộng sẽ có 800 bệnh nhân Pháp bị nhiễm virus SARS-CoV-2 tham gia chương trình thử nghiệm này. Họ được chia thành 4 nhóm.

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